Back to top
more

Lantheus (LNTH)

(Delayed Data from NSDQ)

$97.33 USD

97.33
648,582

+0.07 (0.07%)

Updated Aug 9, 2024 04:00 PM ET

After-Market: $97.39 +0.06 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?

Smart Beta ETF report for FYX

Are Medical Stocks Lagging Lantheus (LNTH) This Year?

Here is how Lantheus Holdings (LNTH) and argenex SE (ARGX) have performed compared to their sector so far this year.

Shaun Pruitt headshot

3 Top Ranked Stocks for Exposure to the Medical Sector

The healthcare business offers attractive defensive attributes that are so valuable in the current uncertain environment. As such, adding healthcare stocks to the portfolio brings much needed diversification.

Vaishali Doshi headshot

4 Top-Performing Liquid Stocks for Attractive Returns in 2022

Here are four top-ranked liquid stocks, Lantheus (LNTH), Cavco (CVCO), Pure Storage (PSTG) and Perion Network (PERI), which investors can add to their portfolio for returns.

Zacks.com featured highlights include Alliance Resource Partners, Digi International, MGP Ingredients, Lantheus and Carter Bankshares

Alliance Resource Partners, Digi International, MGP Ingredients, Lantheus and Carter Bankshares have been highlighted in this Screen of The Week article.

Bryan Hayes headshot

A Simple System to Identify Winning Stocks in Volatile Markets

Following a system rather than relying on predictions is going to produce much more favorable results over time.

Nalak Das headshot

5 Stocks With Recent Price Strength in an Uncertain September

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MGPI, LNTH, CARE, ARLP and DGII.

Why Should You Add Ensign Group (ENSG) to Portfolio Now?

Ensign Group (ENSG) benefits from a growing healthcare portfolio as a result of multiple facility buyouts. Solid cash-generating abilities empower ENSG to invest in growth-related initiatives.

Here's What Could Help Lantheus Holdings (LNTH) Maintain Its Recent Price Strength

If you are looking for stocks that are well positioned to maintain their recent uptrend, Lantheus Holdings (LNTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Factors that Make Humana (HUM) an Attractive Bet Now

Humana (HUM) continues to gain on continued top-line growth resulting from its solid Medicaid and Medicare businesses. A strong cash position enables HUM to undertake growth-related investments.

Zacks.com featured highlights include Lantheus, Cavco, Globant and Perion Network

Lantheus, Cavco, Globant and Perion Network are part of Zacks Screen of the Week article.

Vaishali Doshi headshot

Bet on These 4 Top-Performing Liquid Stocks for Robust Returns

Here are four top-ranked liquid stocks, Lantheus (LNTH), Cavco (CVCO), Globant (GLOB) and Perion Network (PERI), which investors can add to their portfolio for returns.

Here is What to Know Beyond Why Lantheus Holdings, Inc. (LNTH) is a Trending Stock

Lantheus Holdings (LNTH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Teladoc Health (TDOC) Ties Up to Upgrade RPM Care in Canada

Teladoc Health (TDOC) teams up with Cloud DX to bring its virtual care capabilities to the latter's platform and dispense advanced RPM solutions to the Canadian residents.

Does Lantheus Holdings (LNTH) Have the Potential to Rally 26% as Wall Street Analysts Expect?

The consensus price target hints at a 26.4% upside potential for Lantheus Holdings (LNTH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Lantheus Holdings, Inc. (LNTH) Soars to 52-Week High, Time to Cash Out?

Lantheus Holdings (LNTH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Is Trending Stock Lantheus Holdings, Inc. (LNTH) a Buy Now?

Lantheus Holdings (LNTH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Here's What Could Help Lantheus Holdings (LNTH) Maintain Its Recent Price Strength

If you are looking for stocks that are well positioned to maintain their recent uptrend, Lantheus Holdings (LNTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Indrajit Bandyopadhyay headshot

4 Stocks to Watch Amid Recovering Medical Products Industry

Despite the COVID-induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ZBH, BIO, LNTH and HAE are well-poised to gain from the favorable factors.

Zacks.com featured highlights include Cadence Design Systems, Lantheus Holdings, Cavco Industries and Perion Network

Cadence Design Systems, Lantheus Holdings, Cavco Industries and Perion Network are part of Zacks Screen of the Week article.

Vaishali Doshi headshot

Snap Up These 4 Top-Ranked Liquid Stocks for Solid Gains

Here are four top-ranked liquid stocks, Cadence Design Systems (CDNS), Lantheus (LNTH), Cavco (CVCO) and Perion Network (PERI), which investors can add to their portfolio for returns.

Lantheus Holdings, Inc. (LNTH) Hits Fresh High: Is There Still Room to Run?

Lantheus Holdings (LNTH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Is Most-Watched Stock Lantheus Holdings, Inc. (LNTH) Worth Betting on Now?

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Change Healthcare (CHNG) Q1 Earnings & Revenues Miss Estimates

Change Healthcare's (CHNG) fiscal first-quarter 2023 results benefit from solid performance across Software and Analytics, Network Solutions and Enterprise Imaging segments.